Third Harmonic Bio Inc (THRD)

Engitix appoints two additional international biotech industry leaders as Scientific Advisors - GlobeNewswire

GlobeNewswire

Engitix appoints two additional international biotech industry leaders as Scientific Advisors - Yahoo Finance UK

Yahoo Finance UK

Trading (THRD) With Integrated Risk Controls - Stock Traders Daily

Stock Traders Daily

Esperion Therapeutics (NASDAQ:ESPR) Stock Quotes, Forecast and News Summary - Benzinga

Benzinga

Esperion closes down 16% following BofA downgrade - Seeking Alpha

Seeking Alpha

Stock Market Recap: Third Harmonic Bio Inc (THRD) Concludes at 12.32, a -4.86 Surge/Decline – DWinneX - The Dwinnex

The Dwinnex

Stifel starts Third Harmonic at buy, cites mast cell disease approach (NASDAQ:THRD) - Seeking Alpha

Seeking Alpha

Stifel starts Third Harmonic Bio with buy and a target price of $23 By Investing.com - Investing.com Australia

Investing.com Australia

Stifel starts Third Harmonic Bio with buy and a target price of $23 By Investing.com - Investing.com

Investing.com

Stifel starts Third Harmonic Bio with buy and a target price of $23 By Investing.com - Investing.com

Investing.com

Where are the Opportunities in (THRD) - Stock Traders Daily

Stock Traders Daily

Third harmonic exec sells $7k in stock, exercises options By Investing.com - Investing.com

Investing.com

Third harmonic exec sells $7k in stock, exercises options By Investing.com - Investing.com

Investing.com

Raymond James Initiates Coverage of Third Harmonic Bio (THRD) with Outperform Recommendation - MSN

MSN

Raymond James Initiates Coverage of Third Harmonic Bio (THRD) with Outperform Recommendation - MSN

MSN

Third Harmonic Bio Announces Executive Changes and Voting Results - TipRanks.com - TipRanks

TipRanks

Raymond James Initiates Coverage of Third Harmonic Bio (THRD) with Outperform Recommendation - MSN

MSN

When the Price of (THRD) Talks, People Listen - Stock Traders Daily

Stock Traders Daily

Electra Therapeutics Builds Leadership Team with Appointment of Dr. Graham Parry as Chief Scientific Officer and Dr ... - Lelezard

Lelezard

Electra Therapeutics Builds Leadership Team with Appointment of Dr. Graham Parry as Chief Scientific Officer and Dr ... - Business Wire

Business Wire

Electra Therapeutics Builds Leadership Team with Appointment of Dr. Graham Parry as Chief Scientific Officer and Dr ... - Business Wire

Business Wire

Ratio Review: Analyzing Third Harmonic Bio Inc (THRD)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex

The Dwinnex

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference - ForexTV.com

ForexTV.com

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire Inc.

Third harmonic bio exec sells $14.6k in stock - Investing.com Canada

Investing.com Canada

Third harmonic bio exec sells $14.6k in stock By Investing.com - Investing.com

Investing.com

Third harmonic bio exec sells $14.6k in stock - Investing.com UK

Investing.com UK

Third Harmonic Bio Inc (THRD) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily

Knox Daily

Third Harmonic Bio exec sells shares worth over $331k - Investing.com Nigeria

Investing.com Nigeria

Third Harmonic Bio exec sells shares worth over $331k - Investing.com Canada

Investing.com Canada

Third Harmonic Bio exec sells shares worth over $331k - Investing.com

Investing.com

Third Harmonic Bio exec sells shares worth over $331k - Investing.com UK

Investing.com UK

Third Harmonic Bio exec sells shares worth over $331k By Investing.com - Investing.com

Investing.com

Third Harmonic hires Dinsmore as CSO - BioCentury

BioCentury

Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector

Zacks Investment Research

Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector - Zacks Investment Research

Zacks Investment Research

Third Harmonic Bio Releases New Corporate Presentation - TipRanks.com - TipRanks

TipRanks

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update - 15.05.2024 - wallstreet:online

wallstreet:online

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update - 15.05.2024 - wallstreet:online

wallstreet:online

Third Harmonic Bio Releases New Corporate Presentation - TipRanks.com - TipRanks

TipRanks

AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal - MSN

MSN

(THRD) Trading Signals - Stock Traders Daily

Stock Traders Daily

AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal - Yahoo Finance UK

Yahoo Finance UK

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates - Yahoo Finance UK

Yahoo Finance UK

AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal - Zacks Investment Research

Zacks Investment Research

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates - Zacks Investment Research

Zacks Investment Research

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates - Zacks Investment Research

Zacks Investment Research

Third harmonic bio CEO sells over $246k in stock - Investing.com Australia

Investing.com Australia

Third harmonic bio CEO sells over $246k in stock - Investing.com

Investing.com

Third harmonic bio CEO sells over $246k in stock - Investing.com Canada

Investing.com Canada